4.4 Article

Optimized synthesis of anti-COVID-19 drugs aided by retrosynthesis software

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2

Hailei Su et al.

Summary: This article summarizes and analyzes recent studies on the molecular mechanisms of promising antiviral drugs for COVID-19, focusing on viral targets such as spike glycoprotein and host proteases, aiming to inspire new ideas for drug design and optimization in the future.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Infectious Diseases

Role of favipiravir in the treatment of COVID-19

Shashank Joshi et al.

Summary: Favipiravir has shown promising results in clinical studies worldwide, demonstrating potential efficacy against COVID-19, and is being included in treatment protocols by multiple countries.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Review Infectious Diseases

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

Toshie Manabe et al.

Summary: The study suggests that favipiravir shows promising efficacy in treating patients with COVID-19, inducing viral clearance within 7 days and contributing to clinical improvement within 14 days. The drug is especially effective for patients with mild-to-moderate illness. However, additional well-designed studies are needed to determine the optimal dosage and duration of treatment.

BMC INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software

Yingfu Lin et al.

Summary: COVID-19 has revealed the fragility of supply chains, leading researchers to develop a methodology for finding pathways to pharmaceutical targets that avoid low-supply materials. The global disruption caused by the pandemic has stressed supply chains, prompting multiple drug repurposing studies for COVID-19. By utilizing retrosynthetic software, alternate chemical supply chains have been identified for antiviral drugs, with experimental validation of new routes.

NATURE COMMUNICATIONS (2021)

Editorial Material Biotechnology & Applied Microbiology

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Multidisciplinary Sciences

Rapid repurposing of drugs for COVID-19

R. Kiplin Guy et al.

SCIENCE (2020)

Article Engineering, Multidisciplinary

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Qingxian Cai et al.

ENGINEERING (2020)

Article Chemistry, Organic

Favipiravir - a Modern Antiviral Drug: Synthesis and Modifications

Yulia A. Titova et al.

CHEMISTRY OF HETEROCYCLIC COMPOUNDS (2020)

Article Chemistry, Multidisciplinary

Holistic Prediction of the pKa in Diverse Solvents Based on a Machine-Learning Approach

Qi Yang et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Article Chemistry, Medicinal

COVID-19: Drug Targets and Potential Treatments

Carmen Gil et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

A mobile robotic chemist

Benjamin Burger et al.

NATURE (2020)

Review Pharmacology & Pharmacy

Candidate drugs against SARS-CoV-2 and COVID-19

Dwight L. McKee et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Chemistry, Multidisciplinary

A Machine Learning Protocol for Predicting Protein Infrared Spectra

Sheng Ye et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Letter Critical Care Medicine

Effect of favipiravir and an anti-inflammatory strategy for COVID-19

Hitoshi Yamamura et al.

CRITICAL CARE (2020)

Article Chemistry, Multidisciplinary

Automatic retrosynthetic route planning using template-free models

Kangjie Lin et al.

CHEMICAL SCIENCE (2020)

Article Multidisciplinary Sciences

A robotic platform for flow synthesis of organic compounds informed by AI planning

Connor W. Coley et al.

SCIENCE (2019)

Article Chemistry, Multidisciplinary

Molecular Transformer: A Model for Uncertainty-Calibrated Chemical Reaction Prediction

Philippe Schwaller et al.

ACS CENTRAL SCIENCE (2019)

Review Chemistry, Multidisciplinary

Synthetic organic chemistry driven by artificial intelligence

A. Filipa de Almeida et al.

NATURE REVIEWS CHEMISTRY (2019)

Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region

David C. McGowan et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Multidisciplinary

The complete synthesis of favipiravir from 2-aminopyrazine

Qi Guo et al.

CHEMICAL PAPERS (2019)

Review Chemistry, Multidisciplinary

Machine Learning in Computer-Aided Synthesis Planning

Connor W. Coley et al.

ACCOUNTS OF CHEMICAL RESEARCH (2018)

Article Multidisciplinary Sciences

Planning chemical syntheses with deep neural networks and symbolic AI

Marwin H. S. Segler et al.

NATURE (2018)

Article Multidisciplinary Sciences

Accelerated discovery of stable lead-free hybrid organic-inorganic perovskites via machine learning

Shuaihua Lu et al.

NATURE COMMUNICATIONS (2018)

Review Multidisciplinary Sciences

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Yousuke Furuta et al.

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)

Article Chemistry, Multidisciplinary

Retrosynthetic Reaction Prediction Using Neural Sequence-to-Sequence Models

Bowen Liu et al.

ACS CENTRAL SCIENCE (2017)

Article Chemistry, Multidisciplinary

A practical and step-economic route to Favipiravir

Feng-Liang Liu et al.

CHEMICAL PAPERS (2017)

Article Biochemistry & Molecular Biology

A General Synthesis of C8-Arylpurine Phosphoramidites

Vorasit Vongsutilers et al.

MOLECULES (2009)